![Biao He](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Biao He
Direttore/Membro del Consiglio presso BioEclipse Therapeutics, Inc.
Profilo
Biao He is currently a Director at BioEclipse Therapeutics, Inc. He was previously a Venture Partner at Tsinghua Silicon Valley Capital.
Posizioni attive di Biao He
Società | Posizione | Inizio |
---|---|---|
BioEclipse Therapeutics, Inc.
![]() BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Biao He
Società | Posizione | Fine |
---|---|---|
Tsinghua Silicon Valley Capital
![]() Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Investitore di Private Equity | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Tsinghua Silicon Valley Capital
![]() Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Finance |
BioEclipse Therapeutics, Inc.
![]() BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Biao He